Back to trial detailsIntake questionnaire
Cobimetinib in Refractory Langerhans Cell Histiocytosis (LCH), and Other Histiocytic Disorders
Applying to Dana Farber Cancer Institute, Boston Children's · Boston, Massachusetts
Answer a few short questions to share with the research team.
0 of 3 answered